Santero Therapeutics

Charleroi, Belgium · Founded 2021 · Privately Held (backing)

Developer of antibiotics designed to fight multiple resistant pathogens. Santero Therapeutics is based in Charleroi, Belgium and was founded in 2021. Its last reported valuation was $13.3 million in Mar 2025. It has raised $9.9 million.

Last reported valuation

$13.3M

Oct 2026

Priced at

—

Total raised

$9.9M

Last round

—

How much has Santero Therapeutics raised?

$9.9Macross 0 recorded rounds

Free account

More of Santero Therapeutics with a free account

·Watch Santero Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Santero Therapeutics investors

6 investors are on record for Santero Therapeutics, including SambrInvest, Société Fédérale de Participations et d'Investissement, Université Libre de Bruxelles and Newton BioCapital.

For fundraisers

Raising for a company like Santero Therapeutics?

6 investors have backed Santero Therapeutics.

See all 6 investors →

Frequently asked about Santero Therapeutics

How much has Santero Therapeutics raised?: Santero Therapeutics has raised $9.9M in total across 0 recorded funding rounds.